Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy
NeurologyPublished 1 October 1998
Michael A. Markowitz, Josephine Mauskopf, Michael T. Halpern
Citations32
SJR quartileQ1
SJR score2.40
SNIP1.82
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
The model predicts that use of lamotrigine would be associated with an overall reduction in use of other direct medical care resources (hospitalizations, outpatient visits, diagnostic and laboratory tests, and surgery). For a 10-year time horizon, the estimated cost-effectiveness ratio is $6.9 per seizure-free day gained. The model provides a flexible framework to analyze the effect of new antiepileptic drugs.
Keywords
Medicine
EpilepsiaOutcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy
333 Citations1993David F. Smith, Gus A. Baker +3 more
LTG is effective in reducing seizure frequency and has additional favorable effects on seizure severity, mood, and perceived internal control, according to simple correlation and multiple‐regression analyses.
EpilepsiaSpontaneous Recurrent Seizures in Rats: Amino Acid and Monoamine Determination in the Hippocampus
257 Citations1994Ésper A. Cavalheiro, Maria José da Silva Fernandes +2 more
Findings show important neurochemical changes in the course of establishment of an epileptic focus after brain damage induced by status epilepticus triggered by pilocarpine.
EpilepsiaCost of Epilepsy in the United States: A Model Based on Incidence and Prognosis
242 Citations1994Charles E. Begley, John F. Annegers +3 more
A model of the clinical course of epilepsy from onset until remission or death has been developed for six prognostic groups, including survival, use and cost of medical care, and time lost from work and housekeeping, to generate preliminary estimates of the lifetime cost of epilepsy.
EpilepsiaLamotrigine Therapy for Partial Seizures: A Multicenter, Placebo‐Controlled, Double‐Blind, Cross‐Over Trial
219 Citations1994John A. Messenheimer, R. Eugene Ramsay +8 more
The addition of twice‐daily LTG to an existing AED regimen was safe, effective, and well tolerated in these medically refractory partial seizure patients.
New England Journal of MedicineCost Effectiveness of Thrombolytic Therapy with Streptokinase in Elderly Patients with Suspected Acute Myocardial Infarction
211 Citations1992Harlan M. Krumholz, Richard C. Pasternak +5 more
Thrombolytic therapy with streptokinase was found to be a beneficial and cost-effective treatment for suspected acute myocardial infarction in elderly patients in a wide variety of clinical circumstances.
EpilepsiaUptake and Costs of Care for Epilepsy: Findings from a U.K. Regional Study
208 Citations1998Ann Jacoby, Debbie Buck +4 more
Both direct and indirect costs of epilepsy care are investigated and the direct costs are measured and valued and the indirect costs are valued.
EpilepsiaRelationship Between Seizure Frequency and Costs and Quality of Life of Outpatients with Partial Epilepsy in France, Germany, and the United Kingdom
134 Citations1997Ben van Hout, Dennis D. Gagnon +7 more
The relationship between seizure frequency and both health care costs and quality of life (QOL) was investigated in a retrospective, cross‐sectional, multicenter study in France, Germany, and the United Kingdom.
NeurologyA double-blind, placebo-controlled study of Vigabatrin three g/day in patients with uncontrolled complex partial seizures
134 Citations1996Jacqueline A. French, Michael Mosier +3 more
It is indicated that 3 g/day vigabatrin is more effective than placebo as add-on therapy in patients with focal epilepsy whose complex partial seizures were difficult to control with established antiepilepsy drug therapy.
Time Preference
115 Citations1996Joseph Lipscomb, Milton C. Weinstein +1 more
Journal of neurosurgeryA cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy
87 Citations1997Joseph T. King, Michael R. Sperling +2 more
The present data indicate that ATL for treatment of intractable temporal lobe epilepsy is a cost-effective use of medical resources and critically dependent on postoperative seizure status and improvement in quality of life.
EpilepsiaCost‐Effectiveness of Anterotemporal Lobectomy in Medically Intractable Complex Partial Epilepsy
86 Citations1997John T. Langfitt
The value of high‐cost health technologies is being increasingly scrutinized by providers of health care and an understanding of the costs and outcomes of high-technology epilepsy care is required to ensure efficient resource allocation.
NeurologyThe impact of new antiepileptic drugs on the prognosis of epilepsy
81 Citations1996Matthew C. Walker, Josemir W. Sander
Assessment of new AEDs in newly diagnosed patients is possibly unethical as it involves denying patients known effective therapy and suggestions that there is a spontaneous remission rate of at least 30% for this group regardless of AED therapy are confounded.
NeurosurgeryDirect Intraoperative Measurement of Human Brain Temperature
56 Citations1997J. Gilbert Stone, Robert Goodman +3 more
Direct intraoperative measurement of human brain temperature is feasible and safe, but accuracy requires that the temperature sensor be inserted at least 2 cm into the cerebral cortex.
PubMedThe clinical efficacy of lamotrigine as an antiepileptic drug.
56 Citations1994John M. Pellock
Multiple studies and clinical usage have shown lamotrigine to be well tolerated, with patients reporting a sense of well-being during drug therapy, and the most frequently reported adverse events are CNS-associated side effects and rash.
EpilepsiaPredicting Outcome of Anterior Temporal Lobectomy Using Simulated Neural Networks
53 Citations1998Jim Grigsby, Ronald E. Kramer +3 more
A model that predicted seizure outcome after ATL was developed, using a simulated neural network (SNN) to determine whether patient selection might be facilitated by application of artifical intelligence.
BMJLong term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome: Table 1
40 Citations1996Matthew C. Walker, Li M. Li +1 more
A follow up audit of patients recruited from 1987 to 1989 into two uncontrolled open label clinical studies of lamotrigine and vigabatrin finds no change in the long term prognosis of refractory epilepsy as measured by mortality and freedom from seizures.
Epilepsy ResearchRemacemide HC1 and its metabolite, FPL 12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture
37 Citations1996Artur W. Wamil, Helen Cheung +2 more
Limitation of high-frequency firing of action potentials by both remacemide HCl and FPL 12495AA may contribute to the anticonvulsant efficacy of these compounds at concentrations overlapping the range required to block glutamatergic hyperexcitability.
SeizureA cost minimization study comparing vigabatrin, lamotrigine and gabapentin for the treatment of intractable partial epilepsy
35 Citations1996David Hughes, O.C. Cockerell
There was little difference between the initial direct cost of treatment, however, the fewer side-effects associated with gabapentin is reflected in the lower total costs of treatment in the first year resulting in savings of 18.52 pounds per patient compared with lamotrigine and 47.18 pounds compared with vigabatrin.
PubMedInternational migration in India: levels, trends and policy implications.
31 Citations1994Shekhar Mukherji
The author investigates recent trends in India's international migration, with a focus on the movement of professionals and other skilled workers to developed countries, and the temporary migration of workers to oil-rich Middle Eastern countries.
SeizureAdjunctive therapy in epilepsy: a cost-effectiveness comparison of alternative treatment options
24 Citations1995Becky O'Neill, Michael Trimble +1 more
A pharmaco-economic study of the administration of adjunctive therapy in patients with chronic epilepsy finds the expected cost per patient of treatment over the 1-year period was up to 50% higher with vigabatrin and lamotrigine compared with clobazam.
PubMedInternational Conference on Population and Development: year-end update.
11 Citations1993Pamela S. Chasek, Goree Lj th
The report summarizes the UN General Assembly's annotated outline of the Cairo document on the preamble, responsibilities, and implementation of the International Conference on Population and Development (ICPD).